Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Evaluation of regional cerebral blood flow with99mTc-d,1 HM-PAO and SPECT

Abstract

The imaging of regional cerebral blood flow (rCBF) by99mTc-d,1 HM-PAO and SPECT is described. Its relevance to clinical syndromes, such as stroke, transient ischemic attacks, various forms of dementia, epilepsy, and subarachnoid hemorrhage, is reported.

This is a preview of subscription content, log in to check access.

References

  1. [1]

    Burns HD, RF Dannals, TE Dannals, AV Kramer, LG Marzilli: Synthesis of tetradentate aminothiol ligands and their technetium complexes. J Labelled Comp Radiopharm 18 (1981) 54–55

  2. [2]

    Cumming SA, G Nechvatal, LR Canning, DP Nowotnik, RD Pickett, RD Neirinckx: Development of Technetium-99m Regional Cerebral Blood Flow Agents based on the Propylene Amine Oxime Ligand (PnAO). Eur J Nucl Med 11 (1985) A22

  3. [3]

    Kung HF, M Blau: Regional intracellular pH shift: a proposed new mechanism for radiopharmaceutical uptake in brain and other tissues. J Nucl Med 21 (1980) 147–152

  4. [4]

    Levin Va A: Relationship of octanol/water partition Coefficient and molecular weight to rat brain capillary permeability. J Med Chem 23 (1980) 682–684

  5. [5]

    Neirinckx RD, DP Nowotnik, RD Pickett, RC Harrison, PJ Ell: Development of a lipophilic99mTc-complex useful for brain perfusion evaluation with conventional SPECT imaging equipment. In:Biersack HJ, C Winkler (eds): Amphetamines and pH-Shift Agents for Brain Imaging: Basic Research and Clinical Results. Walter de Gruyter, Berlin—New York 1986

  6. [6]

    Nowotnik DP, LR Canning, SA Cumming, RC Harrison, B Higley, G Nechvatal, RD Pickett, IM Piper, VJ Bayne, AM Forster, PS Weisner, RD Neirinckx, VA Volkert, DE Troutner, RA Holmes: Development of a99mTc-labelled radiopharmaceutical for cerebral blood flow imaging. Nucl Med Comm 6 (1985) 499–506

  7. [7]

    Sharp PF, FW Smith, HG Gemmell, D Lyall, NTS Evans, D Gvozdanovic, J Davison, DA Tyrrell, RD Pickett, RD Neirinckx: Tc-99m HM-PAO Stereoisomers as potential agents for Imaging Regional Cerebral Blood Flow: Human Volunteer Studies. J Nucl Med 27 (1986) 171–177

  8. [8]

    Volkert WA, DE Troutner, TJ Hoffman, TM Seger, RA Holmes: Tc-99m-propyleneamineoxime (Tc-99m-PnAO); a potential brain radiopharmaceutical, SNM Meeting Abstract. J Nucl Med 24 (1983) p128

  9. [9]

    Yokoyama A, Y Terauchi, K Horiuchi, H Tanka, T Odori, R Morita, T Mori, K Torizuku: Technetium-99m-ketoxal-bis(thiosemicarbazone), an uncharged complex with a tetravalent Tc-99m state, and its excretion into the bile. J Nucl Med 17 (1976) 816–819

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Neirinckx, R.D. Evaluation of regional cerebral blood flow with99mTc-d,1 HM-PAO and SPECT. Neurosurg. Rev. 10, 181–184 (1987). https://doi.org/10.1007/BF01782044

Download citation

Keywords

  • Cerebral blood flow (rCBF)
  • cerebral ischemia
  • dementia
  • technetium